SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-05
👔
Structure Therapeutics Inc.
@GPCR_InsiderForm 4 Filing: Lin Xichen Exercises Options for $4,017.78 of $GPCR
OPTION EXERCISE
⚡ MATERIALITY: 3/10
corporate issuer
Structure Therapeutics Inc.
Ticker: $GPCR
Transaction Value
$4,017.78
Price/Share: $0.17
transaction date
2026-08-04
Shares: 23,634
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Lin Xichen, holds the title of CHIEF SCIENTIFIC OFFICER at Structure Therapeutics Inc..
On 2026-08-04, the insider transacted 23,634 shares.The shares were transacted at a weighted average price of $0.17 per share, resulting in a total market-relevant value of $4,017.78.
Executive Summary Summary
Lin Xichen (CHIEF SCIENTIFIC OFFICER) exercised options for $4K of $GPCR
Post-Transaction Position: 240,777 shares
SEC Accession No: 0001962926-26-000007 (CIK: 1962926)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.